Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab170933-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$11.90
|
|
|
Ab170933-1mg
|
1mg |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$57.90
|
|
|
Ab170933-5mg
|
5mg |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$117.90
|
|
|
Ab170933-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$177.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Belimumab (anti-TNFSF13B) - Primary antibody, specific to TNFSF13B, >95%, high purity, Human IgG1, INHIBITOR of Tumor necrosis factor ligand superfamily member 13B inhibitor |
|---|---|
| Synonyms | ApoL related ligand TALL 1 antibody | B cell Activating Factor antibody | B lymphocyte stimulator antibody | B-cell-activating factor antibody | BAFF antibody | BLyS antibody | CD 257 antibody | CD257 antibody | CD257 antigen antibody | Delta BAFF antibod |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | TNFSF13B |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | INHIBITOR |
| Mechanism of action | INHIBITOR of Tumor necrosis factor ligand superfamily member 13B inhibitor |
| Product Description |
Belimumab (anti-TNFSF13B) is a human IgG1λ monoclonal antibody that inhibits B-cell activating factor (BAFF). Belimumab (anti-TNFSF13B) can be used for systemic lupus erythematosus (SLE) research. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | lambdaC2 |
| SDS-PAGE | 28.2 kDa (Light Chain) & 52.1 kDa (Heavy Chain), under reducing conditions; 175.9 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Purity | >95% |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 356547-88-1 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Belimumab (anti-TNFSF13B) (Ab170933) - SEC
The purity of Belimumab (anti-TNFSF13B) (Ab170933) is more than 95% verified by HPLC.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Sep 30, 2024 | Ab170933 | |
| Certificate of Analysis | Oct 26, 2023 | Ab170933 | |
| Certificate of Analysis | Oct 26, 2023 | Ab170933 |